Pierre Lafolie

Publications
CV
Public outreach and news

Articles

Article: THERAPEUTIC DRUG MONITORING. 2016;38(2):239-245

Pronounced Interindividual But Not Intraindividual Variation in Tamoxifen and Metabolite Levels in Plasma During Adjuvant Treatment of Women With Early Breast Cancer.

Fotoohi AK; Karim H; Lafolie P; Pohanka A; Östervall J; Hatschek T; Vitols S
Article: LAKARTIDNINGEN. 2015;112:C9CL

[Ethical review of research in the grey area. The Ethical Review Act should be widened and case management more efficient].

Lafolie P; Agahi N
Article: VACCINE. 2014;32(45):5967-5974

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.

Neimert-Andersson T; Binnmyr J; Enoksson M; Langebäck J; Zettergren L; Hällgren A-C; Franzén H; Lind Enoksson S; Lafolie P; Lindberg A; Al-Tawil N; Andersson M; Singer P; Grönlund H; Gafvelin G
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2013;47(6):503-508

Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C.

Ehrén I; Hallén Grufman K; Vrba M; Sundelin R; Lafolie P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013;437(2):280-286

Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.

Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Article: CURRENT DRUG DELIVERY. 2013;10(4):404-412

Comparison of uptake mechanisms for anthracyclines in human leukemic cells.

Karim H; Bogason A; Bhuiyan H; Fotoohi AK; Lafolie P; Vitols S
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2011;71(4):514-521

Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia.

Bogason A; Quartino AL; Lafolie P; Masquelier M; Karlsson MO; Paul C; Gruber A; Vitols S
Article: DRUG METABOLISM LETTERS. 2010;4(4):228-232

Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia.

Bogason A; Masquelier M; Lafolie P; Skogastierna C; Paul C; Gruber A; Vitols S
Article: LAKARTIDNINGEN. 2010;107(40):2384-2385

[EU strikes hard against clinical research--an EU project ECRIN builds bridges for clinical trials].

Johansson H; Souri P; Lafolie P
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2010;54(4):435-441

Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children.

Lundeberg S; Stephanson N; Lafolie P; Olsson GL; Stiller C-O; Eksborg S
Article: LAKARTIDNINGEN. 2009;106(5):279-281

[Research without ethical approval occurs--often negligence behind. Review of Karolinska Institute's publications 2006].

Lindelöf B; Lafolie P; Asp P; Forssberg O
Article: PHYTOMEDICINE. 2008;15(6-7):391-399

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.

Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2007;51(3):322-330

The addition of tramadol to morphine via patient-controlled analgesia does not lead to better post-operative pain relief after total knee arthroplasty.

Stiller C-O; Lundblad H; Weidenhielm L; Tullberg T; Grantinger B; Lafolie P; Jansson K-A
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2007;41(4):335-340

Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study.

Ehren I; Volz D; Farrelly E; Berglund L; Brundin L; Hultling C; Lafolie P
Article: LAKARTIDNINGEN. 2006;103(15-16):1169-1170

[Why has the drug trial at Northwick Park Hospital turned out to a disaster?].

Lafolie P
Article: LAKARTIDNINGEN. 2006;103(4):225

[Now no new drugs will be developed!].

Lafolie P
Article: LAKARTIDNINGEN. 2004;101(10):917-920

[More stringent requirements concerning clinical research. The new EU rules come into effect on May 1].

Lafolie P
Article: LAKARTIDNINGEN. 2002;99(51-52):5180-5181

[Reporting of approval by research ethics committee and informed consent should be included in scientific information. A neglected quality indicator].

Lafolie P
Article: LAKARTIDNINGEN. 2002;99(30-31):3132-3134

[Epidemiology versus clinical trial. A five-round-match on scientific reliability].

Lafolie P
Article: LAKARTIDNINGEN. 2000;97(37):4020-4021

[Alarm from expert meeting when it comes to Swedish clinical research. "We are no longer as good as our reputation used to be"].

Lafolie P; Wallentin L
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2000;35(5):464-469

Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.

Fork FT; Lafolie P; Tóth E; Lindgärde F
Article: JOURNAL OF ANALYTICAL TOXICOLOGY. 1996;20(7):541-546

Urine and plasma pharmacokinetics of codeine in healthy volunteers: implications for drugs-of-abuse testing.

Lafolie P; Beck O; Lin Z; Albertioni F; Boréus L
Article: PSYCHOPHARMACOLOGY. 1995;118(2):122-126

Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.

Hiltunen AJ; Lafolie P; Martel J; Ottosson EC; Boreus LO; Beck O; Borg S; Hjemdahl P
Show more

All other publications

Letter: ACTA OPHTHALMOLOGICA. 2016;94(5):e375-e376

More symptoms with sialic receptor-positive adenovirus in epidemic keratoconjunctivitis.

Dahl M; Gerhardsson E; Lafolie P; Allard A; Laurell C-G
Review: CLINICAL EPIDEMIOLOGY. 2015;7:491-507

Ethical aspects of registry-based research in the Nordic countries.

Ludvigsson JF; Håberg SE; Knudsen GP; Lafolie P; Zoega H; Sarkkola C; von Kraemer S; Weiderpass E; Nørgaard M
Review: FRONTIERS IN PHARMACOLOGY. 2013;4:112

A European approach to clinical investigator training.

Boeynaems J-M; Canivet C; Chan A; Clarke MJ; Cornu C; Daemen E; Demotes J; Nys KD; Hirst B; Hundt F; Kassai B; Kerpel-Fronius S; Kiessig L; Klech H; Kraehenbuhl J-P; Lafolie P; Lucht M; Niese D; Pauli-Magnus C; Peters B; Schaltenbrand R; Stockis A; Stykova M; Verheus N; Klingmann I
Editorial comment: NATURE REVIEWS DRUG DISCOVERY. 2013;12(6):407-408

LifeTrain: towards a European framework for continuing professional development in biomedical sciences

Hardman M; Brooksbank C; Johnson C; Janko C; See W; Lafolie P; Klech H; Verpillat P; Linden H
Letter: LAKARTIDNINGEN. 2006;103(24-25):1979

[Final reply: drug companies must be allowed to make profit].

Lafolie P
Letter: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2006;79(3):287-288

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.

Lundblad MS; Ohlsson S; Johansson P; Lafolie P; Eliasson E

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI